Skip to main content
Z

Zhende Medical Co., Ltd. — Investor Relations & Filings

Ticker · 603301 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 990 across all filing types
Latest filing 2026-04-23 Management Reports
Country CN China
Listing Shanghai Stock Exchange 603301

About Zhende Medical Co., Ltd.

Zhende Medical Co., Ltd. specializes in the research, development, manufacturing, and distribution of medical supplies and healthcare solutions. The company’s extensive product portfolio encompasses advanced wound care, surgical infection control, pressure therapy, fixed compression, and sports medicine. Key offerings include specialized dressings, surgical gowns, protective masks, and rehabilitation products designed for both clinical and home use. Zhende Medical focuses on integrating innovation with large-scale production capabilities to serve healthcare institutions and retail markets. By maintaining rigorous quality standards and international certifications, the company provides comprehensive solutions for wound management, surgical safety, and personal health protection, aiming to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
振德医疗关于2025年度“提质增效重回报”行动方案的评估报告暨2026年度“提质增效重回报”行动方案的公告
Management Reports Classification · 1% confidence The document is a standalone, detailed “评估报告暨行动方案” (evaluation report and action plan) issued by the company’s board. It includes a management discussion of 2025 financial performance, business trends, governance enhancements and an outlook/strategic plan for 2026. It is not a statutory Annual Report (10-K) or interim/quarterly report (IR), nor a simple notice or publication announcement (RPA). Instead, it fits the definition of a Management Report (MDA): management’s detailed explanation of financial results, business trends and future outlook.
2026-04-23 Chinese
振德医疗2026年第一季度报告
Interim / Quarterly Report Q1 2026
2026-04-23 Chinese
振德医疗2025年度可持续发展报告暨ESG（环境、社会及治理）报告摘要
Environmental & Social Information Classification · 1% confidence The document is titled “2025年度可持续发展/环境、社会和公司治理报告摘要” (2025 Sustainability / Environmental, Social and Corporate Governance Report Summary). It provides ESG governance structure, materiality assessment, stakeholder engagement, and other sustainability disclosures. It is not a notice of report publication nor a financial report, but an ESG (sustainability) report summary. According to the definitions, this falls under Environmental & Social Information (Code: SR).
2026-04-23 Chinese
振德医疗2025年度独立董事述职报告（倪崖）
Governance Information Classification · 1% confidence The document is titled “2025年度独立董事述职报告” (“Independent Director’s 2025 Annual Work Report”) and contains a detailed self-appraisal by an independent director of board attendance, committee work, duties performed, compliance with governance rules, and recommendations. It is not announcing any board changes (MANG), not an audit report (AR), not an earnings release (ER), nor a proxy statement (PSI). It focuses on governance practices, internal rules, board structure and the independent director’s role, fitting the Governance Information category (CGR).
2026-04-23 Chinese
振德医疗董事会关于独立董事独立性自查情况的专项意见
Governance Information Classification · 1% confidence The document is a short board‐issued opinion on the independence of its current independent directors, referencing listing rules and governance guidelines. There is no change in board composition or financial data; rather it addresses board governance compliance. This aligns with Governance Information (CGR), which covers reports on internal rules, board structure, and governance practices. Thus, the correct classification is CGR.
2026-04-23 Chinese
振德医疗关于召开2025年度暨2026年第一季度业绩说明会的公告
Investor Presentation Classification · 1% confidence The document is a notice from ZhenDe Medical (证券代码：603301) announcing the date, time, format, and participation details for the company’s 2025 Annual and 2026 Q1 “业绩说明会” (performance explanation meeting). It does not contain the actual financial statements or report data but is clearly an investor‐focused presentation session announcement. It is not the Annual Report itself (10-K), not an earnings release (ER), nor a proxy/meeting voting disclosure. The closest match is “Investor Presentation” (IP), as it organizes a presentation for investors on financial performance and invites Q&A.
2026-04-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.